Craig Collard
Chief Executive Officer presso HERON THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Craig A.
Collard was the founder of Cornerstone BioPharma, Inc. (founded in 2004) where he served as Chief Financial Officer from 2010 to 2011.
He was also the founder of Cornerstone Therapeutics, Inc. (founded in 2008) where he held the title of Chairman & Chief Executive Officer from 2008 to 2014.
Additionally, he founded Carolina Pharmaceuticals, Inc. in 2003 and served as President & Chief Executive Officer.
Currently, Mr. Collard is the Chief Executive Officer & Director at Heron Therapeutics, Inc. since 2023.
He is also a Director at BioMarck Pharmaceuticals Ltd., the Cystic Fibrosis Foundation, and the Hilltop Home Foundation.
Since 2018, he has been the Lead Independent Director at Terrascend Corp.
In his former roles, Mr. Collard served as President & Chief Executive Officer of Critical Therapeutics, Inc. He was the President, Chief Executive Officer & Director of Cornerstone Biopharma Holdings, Inc. from 2004 to 2008.
From 2015 to 2021, he held the positions of President & Chief Executive Officer at Veloxis Pharmaceuticals A and Chief Executive Officer & Director at Veloxis Pharmaceuticals, Inc. He was the Chairman of Opiant Pharmaceuticals, Inc. from 2018 to 2023.
He also served as an Independent Director at Sierra Oncology, Inc. from 2020 to 2022.
Prior to that, he was the Director-National Accounts at DJ Pharma, Inc. from 1998 to 2002 and Vice President-Sales at Verum Pharmaceuticals, Inc. from 2002 to 2003.
He also held a position at Dura Pharmaceuticals, Inc. as a Principal.
Mr. Collard obtained his undergraduate degree from Southern Polytechnic State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TERRASCEND CORP.
0.19% | 25/03/2024 | 546 370 ( 0.19% ) | 1 M $ | 31/03/2024 |
HERON THERAPEUTICS INC
0.17% | 03/04/2024 | 248 996 ( 0.17% ) | 689 719 $ | 31/03/2024 |
Posizioni attive di Craig Collard
| Società | Posizione | Inizio |
|---|---|---|
| TERRASCEND CORP. | Director/Board Member | 06/12/2018 |
| HERON THERAPEUTICS, INC. | Chief Executive Officer | 03/04/2023 |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Director/Board Member | - |
| Hilltop Home Foundation | Director/Board Member | - |
Precedenti posizioni note di Craig Collard
| Società | Posizione | Fine |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Chairman | 02/03/2023 |
| SIERRA ONCOLOGY, INC. | Director/Board Member | 01/07/2022 |
| VELOXIS PHARMACEUTICALS A/S | Chief Executive Officer | 01/12/2021 |
Veloxis Pharmaceuticals, Inc.
 Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The private company is based in Edison, NJ. | Chief Executive Officer | 01/12/2021 |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Craig Collard
| Southern Polytechnic State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 16 |
|---|---|
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
| Critical Therapeutics, Inc. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Health Technology |
Cornerstone BioPharma, Inc.
 Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone BioPharma, Inc. develops and commercializes biopharmaceutical products for respiratory disorders. Its products include AlleRx, Balacet, Deconsal, and Spectracef. The company was founded in March 2004 by Craig A. Collard, Chenyqua Baldwin, and Steven Lutz and is headquartered in Cary, NC | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
| Cornerstone Biopharma Holdings, Inc. | |
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Health Services |
| DJ Pharma, Inc. | |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
| Carolina Pharmaceuticals, Inc. | |
| Verum Pharmaceuticals, Inc. | |
| Hilltop Home Foundation | |
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The private company is based in Edison, NJ. | Health Technology |
| Terrascend Corp. |
- Borsa valori
- Insiders
- Craig Collard
